Peter G. Traber - Chief Medical Officer at Cartesian Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
RNAC on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Peter G. Traber since 12 Aug 2025

Reported holdings for Peter G. Traber in Cartesian Therapeutics, Inc.

Form 4 holding Chief Medical Officer

SELECTA BIOSCIENCES INC

Security class
Common Stock
Shares / value
451,826
Estimated value
$930,762
Report date
25 Sep 2023
Price
$2.06
Ownership
Direct

Transaction history for Peter G. Traber in Cartesian Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .